Skip to main content
padlock icon - secure page this page is secure

Lipoatrophy is a thing of the past, or is it?

Buy Article:

$43.00 + tax (Refund Policy)


We describe the development of severe lipoatrophy in a patient treated with biphasic aspart. This complication of insulin therapy was common in the past with the use of animal insulins and became less common with the increasing purification of these and the introduction of recombinant human insulin. This patient developed severe lipoatrophy with the use of a premixed insulin containing the analogue insulin aspart. Lipoatrophy although rare can still occur even with the use of technologically advanced insulin preparations.

Diabet. Med. 24, 1470–1472 (2007)
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Biphasic insulin Aspart; Insulin analogues; Novomix 30; Recombinant human insulin; lipoatrophy

Document Type: Case Report

Publication date: 01 December 2007

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more